Science Current Events | Science News | Brightsurf.com
 

Interferon Current Events | Interferon News | 2

Sort By: Page Views | Date

Genes in the interferon system important in SLE
Two genes with very strong associations with the disease SLE have been identified by a team of scientists headed by researchers at the Department of Medical Sciences at Uppsala University. The findings are being published today on the Web page of the highly prestigious American Journal of Human Genetics. "These findings are probably the... view more... (2005-01-19)

How to increase the chances of remaining virus free Pakistani patients with HCV?
Hepatitis C is a health care problem all over the world, with 130 million patients infected the world over. The treatment is expensive and has variable results according to the genotype of the infecting virus.   view more (2008-05-21)

Protein may be linked to melanoma recurrence
Higher levels of a protein called S-100 in patients with melanoma may correlate with a higher risk of having the disease return.   view more (2007-06-04)

Engineered molecule amplifies body's immune response
By altering a molecule called Stat1, which is involved in cellular immune signaling, scientists have succeeded in making the molecule more responsive and thus more efficient.   view more (2005-09-29)

Hepatitis C responds best to combo of ribavirin and interferon, study concludes
A combination of the drugs ribavirin and interferon is more effective in treating hepatitis C than using interferon alone, but it also increases the risk of side effects, according to a new systematic review of recent evidence.   view more (2005-07-20)

Scientists shine new light on inflammatory diseases
Investigators at Hospital for Special Surgery have identified a new mechanism involved in the pathogenesis of inflammatory diseases such as rheumatoid arthritis.   view more (2008-03-17)

Mutations within a conservative region of HCV affects the therapy
At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide. Approximately 30%-50% of patients respond to interferon/ribavirin combination therapy.   view more (2009-03-31)

Genetic breakthrough supercharges immunity to flu and other viruses
Researchers at McGill University have discovered a way to boost an organism's natural anti-virus defences, effectively making its cells immune to influenza and other viruses.   view more (2008-02-14)

Genetic differences may help explain response to multiple sclerosis treatment
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two.   view more (2008-01-15)

Greasing interferon's gears may pave way to greater therapeutic benefits, fewer side effects
Interferon - a critical protein that mediates the body's defense against a wide variety of infectious agents and tumors - may soon have greater therapeutic value.   view more (2005-10-03)

Early trigger for type-1 diabetes found in mice, Stanford scientists report
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins.   view more (2008-08-27)

Researchers prolong the plasma half-life of biopharmaceutical proteins
Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of the proteins in the body.   view more (2009-09-21)

Depression in MS patients clue to better treatment
Depression increases in some patients with multiple sclerosis over time, according to neuropsychologists, and this research finding could help reduce depression in patients and aid in better treatment strategies.   view more (2006-05-18)

UC Santa Barbara scientists clarify molecular basis of interferon action
Scientists at the University of California, Santa Barbara have made a significant discovery relating to viral infections in humans.   view more (2007-07-20)

Current hepatitis C treatments work equally well, UT Southwestern and national researchers report
The three treatment combinations for clearing the most common form of the hepatitis C virus work equally well with similar side effects, UT Southwestern Medical Center researchers and their colleagues in 13 other institutions have found.   view more (2009-08-07)

Fewer injection site reactions in patients using Avonex
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon® (interferon beta-1b), Copaxone® (glatiramer Acetate) or Rebif ®... view more... (2009-09-11)

Brown Researchers Make Major Signal Transduction Discovery
The chemical process known as acetylation plays a central role in cytokine receptor signal transduction - a fundamental biochemical cascade inside cells that controls the activity of antiviral and tumor-suppressing genes.   view more (2007-10-05)

Mechanisms Involved with Tumor Relapse Identified
Researchers at Virginia Commonwealth University's Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling proteins involved with tumor relapse.   view more (2007-03-14)

2-day results predict ultimate response to therapy in chronic hepatitis C
A new study suggests that previously noted low rates of successful hepatitis C virus (HCV) therapy in African Americans are in large part due to very early differences in the antiviral activity induced by interferon.   view more (2009-03-23)

Immunologists identify biochemical signals that help immune cells remember how to fight infection
Immunology researchers at UT Southwestern Medical Center have discovered how two biochemical signals play unique roles in promoting the development of a group of immune cells employed as tactical assassins.   view more (2009-05-28)
Sort By: Page Views | Date
© 2009 BrightSurf.com